Previous Close | 3.1500 |
Open | 3.1800 |
Bid | 3.1300 x 200 |
Ask | 3.2600 x 200 |
Day's Range | 3.1500 - 3.2280 |
52 Week Range | 2.9800 - 13.8500 |
Volume | |
Avg. Volume | 132,080 |
Market Cap | 134.561M |
Beta (5Y Monthly) | 0.56 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.2300 |
Earnings Date | Feb 26, 2024 - Mar 01, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 15.33 |
Key Insights Significant control over Repare Therapeutics by private equity firms implies that the general public has...
Repare Therapeutics ( NASDAQ:RPTX ) Full Year 2023 Results Key Financial Results Revenue: US$51.1m (down 61% from FY...
CAMBRIDGE, Mass. & MONTREAL, February 29, 2024--Repare Therapeutics Inc. ("Repare" or the "Company") (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate at two upcoming investor conferences. Details for the presentations are as follows.